EUS-guided radiofrequency ablation for pancreatic lesions
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests how safe and effective endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is for treating pancreatic growths that might become cancer or already are cancer. It is for people who are already scheduled to have this procedure as part of their care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a pancreatic lesion that could turn into cancer or is already cancerous
- You are already planning to have a procedure called EUS-RFA to treat this lesion
- You do not have another type of cancer (now or in the past)
- You are able to understand the study and give your consent to take part
- You can make it to all the follow-up appointments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).
This study looks at how doctors use endoscopic ultrasound (EUS) to diagnose and manage tumors in the pancreas and nearby areas. If you have such a tumor, this study may help improve how these conditions are treated.
This study tests a procedure called microwave ablation (using heat to destroy cancer cells) for tumors that are hard to remove with surgery. It aims to see if the procedure is safe and effective when done through a scope in the stomach.
This trial tests a procedure that uses sound waves to heat and destroy part of the tumor, combined with an immunotherapy drug called pembrolizumab (Keytruda) that helps your immune system fight the cancer. It is for people with pancreatic cancer that cannot be removed by surgery or has spread to other parts of the body.
This Phase 2 trial is for people with pancreatic ductal adenocarcinoma (a type of pancreatic cancer) confirmed by biopsy. It tests a new treatment strategy after the cancer is diagnosed and considers people who haven’t had certain chemotherapy yet.
This trial studies an endoscopy-guided procedure that aims to treat certain pancreatic tumors using a targeted heat “burn.” It may help people who have a pancreatic tumor but cannot safely have surgery, or who prefer a non-surgical approach.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.